<DOC>
	<DOC>NCT00190671</DOC>
	<brief_summary>This is the phase 2 portion of a phase 1/2 trial, testing the use of pemetrexed and cyclophosphamide in combination for the treatment of advanced breast cancer. A single arm Phase 1 dose finding (establish maximum tolerated dose) study precedes the randomized phase 2 portion.</brief_summary>
	<brief_title>A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>You must be female and at least 18 years old. You must have been diagnosed with breast cancer. Your prestudy lab tests are within study requirements. You must be willing to take folic acid and vitamin B12. You are pregnant or breastfeeding. You have another illness that your doctor thinks would make you unable to participate. You are currently taking aspirin or aspirinlike medicine and are unable to stop for a few days during each cycle of therapy.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Advanced Breast Cancer</keyword>
</DOC>